March 07, 2016
1 min read
Save

Aldosterone, renin activation may increase risk for diabetes in blacks

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In black adults, activation of the renin-angiotensin-aldosterone system may significantly influence the development of insulin resistance and diabetes, according to study findings published in The Journal of Clinical Endocrinology & Metabolism.

Sherita Hill Golden, MD, MHS, associate professor at Johns Hopkins University School of Medicine, and colleagues evaluated data from the Jackson Heart Study on 3,234 black adults during a median of 8 years to determine the links between aldosterone and renin, and insulin resistance, beta-cell function and incident diabetes.

Sherita Hill Golden

Sherita Hill Golden

Among participants who did not develop diabetes, every 1% increase in log-transformed aldosterone was linked to a 0.18% higher log-transformed homeostasis model assessment for insulin resistance (HOMA-IR) and 0.1% higher log-transformed HOMA-beta (P < .001).

Throughout follow-up, 554 participants developed diabetes. Higher quintiles of log-transformed aldosterone was linked to a significantly higher risk for diabetes (HR = 1.78; fifth vs. first quintile, 95% CI, 1.35-2.34) after full adjustment. Compared with the first quintile of log-transformed renin, the fifth quintile was linked to a 35% higher risk for incident diabetes (HR = 1.35; 95% CI, 1.06-1.72).

“Our study suggests that activation of the [renin-angiotensin-aldosterone system] with higher levels of aldosterone and renin are associated with insulin resistance, compensatory increased beta-cell function and incident diabetes in [African Americans], implicating this hormonal pathway not only in the pathophysiology of hypertension, but also diabetes,” the researchers wrote. “Further research exploring the impact of the [renin-angiotensin-aldosterone system] and [renin-angiotensin-aldosterone system] blockage on diabetes prevention in [African Americans], a population with a high prevalence of hypertension, is paramount given the potential to reduce the disparities in diabetes prevalence and cardiometabolic health in [African Americans].” – by Amber Cox

Disclosure: The researchers report no relevant financial disclosures.